Vitality Therapeutics ApS: Financial statements 2022
CVR: 39913003
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Vitality Therapeutics ApS (CVR 39913003) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 389,522 and a net result of DKK 300,062 compared with DKK 0 the year before. Equity in the 2022 report amounted to DKK 333,142. The solvency ratio was 77.6%.
- Gross Profit
- DKK 389,522
- Profit/Loss
- DKK 300,062
- Equity
- DKK 333,142
- Total Assets
- DKK 429,521
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 390K | 300K | 333K | - |
| 2021 | - | 0 | 0 | 33K | - |
| 2020 | - | 0 | 0 | -7K | - |
| 2019 | - | 0 | 0 | -7K | - |
Official annual report
Keep an eye on Vitality Therapeutics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Vitality Therapeutics ApS has published its annual report for 2021. Gross profit came to DKK 0, and the net result was DKK 0.
On June 27, 2022, the company changed its name from Darius Moravcik Holding ApS to Vitality Therapeutics ApS.
About Vitality Therapeutics ApS
Vitality Therapeutics ApS was a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company has been dissolved on 24 February 2025. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Darius Moravcik Holding ApS and Darius Moravcik Holding IVS. In 2023, the company reported a gross profit of DKK -329,086 and a net result of DKK -327,857 compared with DKK 300,062 the year before. Equity in the 2023 report amounted to DKK 126,219.
